v3.25.3

Consolidated Condensed Balance Sheets (Unaudited) - USD ($) $ in Thousands	Sep. 30, 2025	Dec. 31, 2024
Current assets:
Cash and cash equivalents	$ 38,929	$ 24,459
Accounts receivable, net	224,943	237,733
Inventories	364,355	346,719
Prepaid expenses and other current assets	33,931	31,096
Total current assets	662,158	640,007
Property, plant and equipment, net	112,036	115,793
Goodwill	806,916	805,358
Other intangible assets, net	593,107	617,663
Other assets	148,271	127,426
Total assets	2,322,488	2,306,247
Current liabilities:
Current portion of long-term debt	746	715
Accounts payable	107,087	102,248
Accrued compensation and benefits	76,125	65,368
Other current liabilities	130,741	109,799
Total current liabilities	314,699	278,130
Long-term debt	853,007	905,066
Deferred income taxes	74,857	74,076
Other long-term liabilities	71,662	86,294
Total liabilities	1,314,225	1,343,566
Commitments and contingencies
Shareholders' equity:
Preferred stock, par value $.01 per share; authorized 500,000 shares; none outstanding	0	0
Common stock, par value $0.01 per share; 100,000,000 shares authorized; 31,299,194 shares issued in 2025 and 2024, respectively	313	313
Paid-in capital	498,672	476,575
Retained earnings	572,027	560,277
Accumulated other comprehensive loss	(49,232)	(58,857)
Less: 344,143 and 397,860 shares of common stock in treasury, at cost, in 2025 and 2024, respectively	(13,517)	(15,627)
Total shareholders’ equity	1,008,263	962,681
Total liabilities and shareholders’ equity	$ 2,322,488	$ 2,306,247

Carrying value as of the balance sheet date of liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received that are used in an entity's business. Used to reflect the current portion of the liabilities (due within one year or within the normal operating cycle if longer).

CONMED Corp 10-Q